nach oben

Erschienen in:

01.12.2015 | Original Article

Social Network Characteristics Moderate the Association Between Stigmatizing Attributions About HIV and Non-adherence Among Black Americans Living with HIV: a Longitudinal Assessment

verfasst von: Laura M. Bogart, PhD, Glenn J. Wagner, PhD, Harold D. Green Jr., PhD, Matt G. Mutchler, PhD, David J. Klein, MS, Bryce McDavitt, PhD

Erschienen in: Annals of Behavioral Medicine | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Stigma may contribute to HIV-related disparities among HIV-positive Black Americans.

Purpose

We examined whether social network characteristics moderate stigma’s effects.

Methods

At baseline and 6 months post-baseline, 147 HIV-positive Black Americans on antiretroviral treatment completed egocentric social network assessments, from which we derived a structural social support capacity measure (i.e., ability to leverage support from the network, represented by the average interaction frequency between the participant and each alter). Stigma was operationalized with an indicator of whether any social network member had expressed stigmatizing attributions of blame or responsibility about HIV. Daily medication adherence was monitored electronically.

Results

In a multivariate regression, baseline stigma was significantly related to decreased adherence over time. The association between stigma and non-adherence was attenuated among participants who increased the frequency of their interactions with alters over time.

Conclusions

Well-connected social networks have the potential to buffer the effects of stigma.

The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Available at http://aids.gov/federal-resources/national-hiv-aids-strategy/nhas.pdf. Accessibility verified March 5, 2014.

Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: Uptake of and responses to antiretroviral therapy. AIDS. 2004; 18: 2145-2151.CrossRefPubMed

Simoni JM, Huh D, Wilson IB, et al. Racial/ethnic disparities in ART adherence in the United States: Findings from the MACH14 study. J Acquir Immune Defic Syndr. 2012; 60: 466-472.PubMedCentralCrossRefPubMed

Giordano TP, White AC, Sajja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003; 32: 399-405.CrossRefPubMed

Centers for Disease Control and Prevention. HIV in the United States: The stages of care. Available at http://www.cdc.gov/hiv/pdf/research_mmp_stagesofcare.pdf. Accessibility verified June 11 2015.

Earnshaw VA, Bogart LM, Dovidio JF, Williams DR. Stigma and racial/ethnic HIV disparities: Moving towards resilience. Am Psychol. 2013; 68: 225-236.PubMedCentralCrossRefPubMed

Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Ann Behav Med. 2010; 40: 184-190.PubMedCentralCrossRefPubMed

Vanable PA, Carey MP, Blair DC, Littlewood RA. Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women. AIDS Behav. 2006; 10: 473-482.PubMedCentralCrossRefPubMed

Rajabiun S, Mallinson RK, McCoy K, et al. ‘Getting me back on track’: The role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care STDS. 2007; 21: S20-S29.CrossRefPubMed

10.

Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: Systematic review and meta-synthesis. J Int AIDS Soc. 2013; 16: 18640.PubMedCentralCrossRefPubMed

11.

Pascoe EA, Smart RL. Perceived discrimination and health: A meta-analytic review. Psychol Bull. 2009; 135: 531-554.PubMedCentralCrossRefPubMed

12.

Bogart LM, Cowgill BO, Kennedy D, et al. HIV-related stigma among people with HIV and their families: A qualitative analysis. AIDS Behav. 2008; 12: 244-254.CrossRefPubMed

13.

Bogart LM, Chetty S, Giddy J, et al. Barriers to care among people living with HIV in South Africa: Contrasts between patient and healthcare provider perspectives. AIDS Care. 2013; 25: 843-853.PubMedCentralCrossRefPubMed

14.

Konkle-Parker DJ, Erlen JA, Dubbert PM. Barriers and facilitators to medication adherence in a southern minority population with HIV disease. J Assoc Nurses AIDS Care. 2008; 19: 98-104.PubMedCentralCrossRefPubMed

15.

Mbonu NC, van den Borne B, De Vries NK. Stigma of people with HIV/AIDS in Sub-Saharan Africa: A literature review. J Trop Med. 2009; 2009: 145891.PubMedCentralCrossRefPubMed

16.

Okoror TA, Falade CO, Olorunlana A, Walker EM, Okareh OT. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria. AIDS Patient Care STDS. 2013; 27: 55-64.CrossRefPubMed

17.

Gilbert L, Walker L. ‘My biggest fear was that people would reject me once they knew my status…’: Stigma as experienced by patients in an HIV/AIDS clinic in Johannesburg, South Africa. Health Soc Care Community. 2010; 18: 139-146.CrossRefPubMed

18.

Bogart LM, Landrine H, Galvan FH, Wagner GJ, Klein DJ. Perceived discrimination and physical health among HIV-positive Black and Latino men who have sex with men. AIDS Behav. 2013; 17: 1431-1441.PubMedCentralCrossRefPubMed

19.

Cohen S. Social relationships and health. Am Psychol. 2004; 59: 676-684.CrossRefPubMed

20.

Williams DR, Mohammed SA. Discrimination and racial disparities in health: Evidence and needed research. J Behav Med. 2009; 32: 20-47.PubMedCentralCrossRefPubMed

21.

Brondolo E, Rieppi R, Kelly KP, Gerin W. Perceived racism and blood pressure: A review of the literature and conceptual and methodological critique. Ann Behav Med. 2003; 25: 55-65.CrossRefPubMed

22.

Landrine H, Klonoff EA. The schedule of racist events: A measure of racial discrimination and a study of its negative physical and mental health consequences. J Black Psychol. 1996; 22: 144-168.CrossRef

23.

Janicke DM, Gray WN, Kahhan NA, et al. Brief report: The association between peer victimization, prosocial support, and treatment adherence in children and adolescents with inflammatory bowel disease. J Pediatr Psychol. 2009; 34: 769-773.CrossRefPubMed

24.

Wills TA, Ainette MG. Social Networks and Social Support. In: Baum A, Revenson TA, eds. Handbook of health psychology. New York: Taylor & Francis; 2012: 465-492.

25.

Newsom JT, Rook KS, Nishishiba M, Sorkin DH, Mahan TL. Understanding the relative importance of positive and negative social exchanges: Examining specific domains and appraisals. J Gerontol B Psychol Sci Soc Sci. 2005; 60: 304-P312.CrossRef

26.

Newsom JT, Mahan TL, Rook KS, Krause N. Stable negative social exchanges and health. Health Psychol. 2008; 27: 78-86.CrossRefPubMed

27.

Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991; 32: 705-714.CrossRefPubMed

28.

McCarty C. Measuring structure in personal networks. J Soc Struct. 2002; 3: 1.

29.

McCarty C, Bernard H, Killworth P, Shelley GA, Johnsen EC. Eliciting representative samples of personal networks. Soc Networks. 1997; 19: 303-323.CrossRef

30.

Campbell K, Lee B. Name generators in surveys of personal networks. Soc Networks. 1991; 13: 203-221.CrossRef

31.

McCarty C, Kilworth PD, Rennell J. Impact of methods for reducing respondent burden on personal network structural measures. Soc Networks. 2007; 29: 300-315.CrossRef

32.

Herek GM, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: Prevalence and trends, 1991–1999. Am J Public Health. 2002; 92: 371-377.PubMedCentralCrossRefPubMed

33.

Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas in people living with HIV/AIDS: The Internalized AIDS-Related Stigma Scale. AIDS Care. 2009; 21: 87-93.CrossRefPubMed

34.

Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002; 17: 377-381.PubMedCentralCrossRefPubMed

35.

Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000; 14: 357-366.CrossRefPubMed

36.

Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011; 45: 372-379.CrossRefPubMed

37.

Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006; 43: 939-941.CrossRefPubMed

38.

Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acquir Immune Defic Syndr. 2007; 45: 4-8.CrossRefPubMed

39.

Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndr. 2010; 53: 648-655.PubMedCentralPubMed

40.

Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004; 19: 1111-1117.PubMedCentralCrossRefPubMed

41.

Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL. Gender disparities in HIV treatment outcomes following release from jail: Results from a multicenter study. Am J Public Health. 2014; 104: 434-441.PubMedCentralCrossRefPubMed

42.

Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: The impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004; 9: 713-719.PubMed

43.

Maman S, Abler L, Parker L, et al. A comparison of HIV stigma and discrimination in five international sites: The influence of care and treatment resources in high prevalence settings. Soc Sci Med. 2009; 68: 2271-2278.PubMedCentralCrossRefPubMed

44.

Green HD, Hoover MA, Wagner GJ, Ryan GW, Ssegujja E. Measuring agreement between egos and alters: Understanding informant accuracy in personal network studies. Field Methods. 2013; 26: 126-140.CrossRef

45.

Rice E, Milburn NG, Rotheram-Borus MJ. Pro-social and problematic social network influences on HIV/AIDS risk behaviours among newly homeless youth in Los Angeles. AIDS Care. 2007; 19: 697-704.PubMedCentralCrossRefPubMed

46.

Valente TW, Vlahov D. Selective risk taking among needle exchange participants: Implications for supplemental interventions. Am J Public Health. 2001; 91: 406-411.PubMedCentralCrossRefPubMed

47.

Costenbader EC, Astone NM, Latkin CA. The dynamics of injection drug users’ personal networks and HIV risk behaviors. Addiction. 2006; 101: 1003-1013.CrossRefPubMed

48.

El-Bassel N, Gilbert L, Wu E, Chang M. A social network profile and HIV risk among men on methadone: Do social networks matter? J Urban Health. 2006; 83: 602-613.PubMedCentralCrossRefPubMed

49.

Williams CT, Latkin CA. Neighborhood socioeconomic status, personal network attributes, and use of heroin and cocaine. Am J Prev Med. 2007; 32: S203-S210.PubMedCentralCrossRefPubMed

50.

Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: How far have we come? J Int AIDS Soc. 2013; 16: 18734.PubMedCentralCrossRefPubMed

Titel: Social Network Characteristics Moderate the Association Between Stigmatizing Attributions About HIV and Non-adherence Among Black Americans Living with HIV: a Longitudinal Assessment
verfasst von: Laura M. Bogart, PhD
Glenn J. Wagner, PhD
Harold D. Green Jr., PhD
Matt G. Mutchler, PhD
David J. Klein, MS
Bryce McDavitt, PhD
Publikationsdatum: 01.12.2015
Verlag: Springer US
Erschienen in: Annals of Behavioral Medicine / Ausgabe 6/2015
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI: https://doi.org/10.1007/s12160-015-9724-1

Neu in den Fachgebieten Neurologie und Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Social Network Characteristics Moderate the Association Between Stigmatizing Attributions About HIV and Non-adherence Among Black Americans Living with HIV: a Longitudinal Assessment

Abstract

Background

Purpose

Methods

Results

Conclusions

Neu in den Fachgebieten Neurologie und Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Delir kann Demenz begünstigen

Manche Gestagene können das Risiko für Meningeome erhöhen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2015

Predicting Changes Across 12 Months in Three Types of Parental Support Behaviors and Mothers’ Perceptions of Child Physical Activity

The Interdependence of Advanced Cancer Patients’ and Their Family Caregivers’ Mental Health, Physical Health, and Self-Efficacy over Time

Heightened Temporal Summation of Pain in Patients with Functional Gastrointestinal Disorders and History of Trauma

Illness Schema Activation and the Effects of Illness Seasonality on Accessibility of Implicit Illness-Related Information

Predicting Scheduling and Attending for an Oral Cancer Examination

Sexual Minority Stressors, Internalizing Symptoms, and Unhealthy Eating Behaviors in Sexual Minority Youth

Neu in den Fachgebieten Neurologie und Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Delir kann Demenz begünstigen

Manche Gestagene können das Risiko für Meningeome erhöhen